Fisher Asset Management Portfolio holdings
Fisher Asset Management, LLC, operating as Fisher Investments, was founded in 1979 by Ken Fisher and is headquartered in Plano, Texas, following a relocation from Camas, Washington, in 2023. As an independent, fee-only investment adviser, it manages over $275 billion in assets for individual and institutional investors globally as of June 2024, offering tailored portfolio management through its Private Client Group and Institutional Group. Known for its active, top-down investment approach guided by a five-member Investment Policy Committee, the firm emphasizes asset allocation and has expanded internationally with offices in eight countries, including a wholly owned subsidiary, Fisher Investments Europe Limited, in London. With Ken Fisher as executive chairman and co-chief investment officer, succeeded as CEO by Damian Ornani in 2016, Fisher Investments blends a legacy of innovation with a client-first philosophy, recently spinning off its 401(k) Solutions into Fisher Retirement Solutions in 2024.
Top Buys
| 1 |
iShares Expanded Tech-Software Sector ETF
IGV
|
$1.22B |
| 2 |
Charles Schwab
SCHW
|
$1.11B |
| 3 |
Walmart
WMT
|
$989M |
| 4 |
Blackrock
BLK
|
$837M |
| 5 |
Starbucks
SBUX
|
$806M |
Top Sells
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
$1.06B |
| 2 |
Visa
V
|
$924M |
| 3 |
Apple
AAPL
|
$897M |
| 4 |
Costco
COST
|
$846M |
| 5 |
Alibaba
BABA
|
$825M |
Sector Composition
| 1 | Technology | 26.2% |
| 2 | Financials | 11.9% |
| 3 | Healthcare | 9.86% |
| 4 | Consumer Discretionary | 9.75% |
| 5 | Communication Services | 6.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
Collegium Pharmaceutical
COLL
$1.21B
| $1.05M | ﹤0.01% |
65,219
| – | – |
|
|
RDUS
602
DELISTED
Radius Recycling
RDUS
| $1.03M | ﹤0.01% |
36,066
| – | – |
|
603
Cogent Biosciences
COGT
$1.82B
| $1.02M | ﹤0.01% |
+68,569
| New | +$1.02M |
|
604
WPP
WPP
$5.83B
| $1.02M | ﹤0.01% |
+24,810
| New | +$1.02M |
|
605
Vanda Pharmaceuticals
VNDA
$272M
| $1.01M | ﹤0.01% |
102,656
+33,068
| +48% | +$327K |
|
606
Teleflex
TFX
$5.78B
| $1.01M | ﹤0.01% |
5,030
-290
| -5% | -$58.4K |
|
607
iShares Core S&P 500 ETF
IVV
$664B
| $1.01M | ﹤0.01% |
2,817
-1,179
| -30% | -$423K |
|
|
KDNY
608
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $1M | ﹤0.01% |
+51,007
| New | +$1M |
|
609
Ironwood Pharmaceuticals
IRWD
$188M
| $1M | ﹤0.01% |
96,741
-48,045
| -33% | -$498K |
|
610
Vanguard Industrials ETF
VIS
$6.11B
| $1M | ﹤0.01% |
6,359
-50
| -0.8% | -$7.88K |
|
611
KraneShares CSI China Internet ETF
KWEB
$8.55B
| $995K | ﹤0.01% |
40,395
-743,039
| -95% | -$18.3M |
|
612
Lockheed Martin
LMT
$108B
| $993K | ﹤0.01% |
2,571
-101
| -4% | -$39K |
|
613
Credicorp
BAP
$20.7B
| $989K | ﹤0.01% |
8,057
-1,408
| -15% | -$173K |
|
614
iShares MSCI ACWI ETF
ACWI
$22.1B
| $988K | ﹤0.01% |
12,691
-296
| -2% | -$23K |
|
615
Pricesmart
PSMT
$3.38B
| $985K | ﹤0.01% |
17,102
+2,269
| +15% | +$131K |
|
616
Stellantis
STLA
$26.2B
| $982K | ﹤0.01% |
+82,970
| New | +$982K |
|
617
iShares TIPS Bond ETF
TIP
$13.6B
| $968K | ﹤0.01% |
9,231
-835
| -8% | -$87.6K |
|
618
iShares MSCI Spain ETF
EWP
$1.36B
| $965K | ﹤0.01% |
48,709
-3,858
| -7% | -$76.4K |
|
619
Replimune Group
REPL
$494M
| $954K | ﹤0.01% |
+55,258
| New | +$954K |
|
620
Celldex Therapeutics
CLDX
$1.52B
| $953K | ﹤0.01% |
+33,893
| New | +$953K |
|
621
Hologic
HOLX
$14.8B
| $939K | ﹤0.01% |
14,559
-104
| -0.7% | -$6.71K |
|
622
GE Aerospace
GE
$296B
| $936K | ﹤0.01% |
24,279
-7,425
| -23% | -$286K |
|
623
Affiliated Managers Group
AMG
$6.54B
| $928K | ﹤0.01% |
8,300
+189
| +2% | +$21.1K |
|
624
Columbia Banking Systems
COLB
$8.05B
| $923K | ﹤0.01% |
31,955
+155
| +0.5% | +$4.48K |
|
625
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$21.6B
| $919K | ﹤0.01% |
18,649
+5,604
| +43% | +$276K |
|